maintained in that position throughout the biopsy. The biopsy forceps was then passed through the suction channel and extended to the lung periphery. If the patient reported pain, the forceps was immediately withdrawn several centimeters. Once the forceps was in proper position, the patient was asked to exhale completely. As the patient exhales, the forceps was advanced 1 to 2 cm in an open position, closed, and then removed from the bronchoscope to obtain the specimen. This procedure was repeated three to five times to obtain adequate samples.
RESULTS

Indications
Of the 4,273 bronchoscopies performed, 3,686 (86.3%) were performed for diagnostic purposes, 447 (10.4%) for therapeutic purposes, and 140 (3.3%) were performed on normal volunteers for research purposes. These procedures included 2,493 BALs and 173 transbronchial biopsies. The major diagnostic indications included obtaining lower respiratory tract secretions for suspected infection (52% of all FFBs), evaluating lung lesions of unknown etiology observed on chest radiograph (17% of all FBB), investigation of hemoptysis, assessment of airway patency, BAL in the diagnosis and staging of patients with interstitial lung disease, obtaining tissue for diagnosis, and the diagnostic evaluation of chronic cough. The other diagnostic indications, occurring <1%, included evaluation of suspicious sputum cytologic findings, evaluation of tracheal injury due to endotracheal tube placement, inhalation injury, evaluation of superior vena cava syndrome, evaluation of unexplained exudative pleural effusion, and evaluation of unexplained vocal cord paralysis ( Table 1) .
The major therapeutic indications included suctioning of retained secretions and mucus plugs (8% of all FBBs), placing intraluminal catheters for endobronchial radiation therapy (brachytherapy), extraction of foreign bodies, and assisting with difficult intubations (Table 1) .
Complications
There were no fatalities associated with FFB. The complications can be divided into major and minor. The major complications occurred in 0.6% of all FFBs performed and included pneumothorax, pulmonary hemorrhage, and respiratory failure ( Table  2 ). Pneumothorax and pulmonary hemorrhage occurred in less than 1% of all the FFBs. However, these The minor complications included 25 patients (0.6%) with laryngospasm that resolved spontaneously, 4 patients (0.1%) with vomiting, 3 episodes of bronchospasm, 2 episodes of vasovagal syncope, and 1 episode of epistaxis (Table 3 ). It is possible that some complications occurred later than 4 h following the procedure and could have been missed by our collection system. DISCUSSION Credle et a12 first reviewed the complications of fiberoptic bronchoscopy in 1974 by a questionnaire sent to 250 physicians. Seventy-eight percent responded with a total of 24,521 procedures reported. The mortality rate was 0.01% and the incidence of major complications was 0.08%. In a similar study, Suratt et a13 surveyed 1,041 owners of flexible fiberoptic bronchoscopes. Thirty-one percent responded for a total of 48,000 procedures. Mortality rate was 0.03% and the incidence of major complications was 0.3%. Both studies may have underestimated the incidence of complications due to under- In our 5-year experience, the mortality rate was 0% and the incidence of major complications was 0.5%. The mortality rate was significantly lower than previously reported. There are several possible explanations. First, both the faculty and technicians have become quite experienced, which may translate into better technique and teaching of pulmonary fellows. All procedures were closely monitored and performed with continuous transcutaneous oxygen saturation monitoring. Selected patients were monitored with continuous electrocardiogram tracings. Transbronchial biopsies were avoided in high-risk patients, which include those with pulmonary hypertension, uremia, and platelet count <60,000/1iL. Resuscitation equipment and trained personnel were always immediately available if a complication occurred.
The complication rate is significantly lower than previously reported for a university teaching hospital but similar to complication rates in nonuniversity hospitals. The most common major complications in our study were pneumothorax, pulmonary hemorrhage, and respiratory failure. The incidence of pneumothorax and pulmonary hemorrhage in transbronchial biopsies was 6.8%. This is significantly less than the 30% incidence reported by Burgher.5 Forty-eight percent of major complications in our study were related to transbronchial biopsy.
The data presented in this study show that FFB can be performed with relative safety in a teaching hospital with appropriate preparation, supervision, and adherence to protocol.
